Costs and Outcomes of Clostridioides difficile Infections in Germany: A Retrospective Health Claims Data Analysis. Read the full article here: https://t.co/F4lRP1HrUU
Association of Antibiotic Route and Outcomes in Children with Methicillin-Resistant Staphylococcus aureus Bacteremic Osteomyelitis. Read the full article here: https://t.co/qi1L0aUX21
Our latest review explores the characteristics and uses of endolysins derived from staphylococcal bacteriophages, as well as their antibacterial effectiveness against Staphylococcus spp. Read the full article here: https://t.co/MkYaFOeYVa
COVID-19 Vaccination Recommendations for Immunocompromised Patient Populations: Delphi Panel and Consensus Statement Generation in the United States
#COVIDー19
Read the full article #OpenAccess here:
https://t.co/OcNGYTXDUn
Bridging the Gap: Delphi Consensus Statements for SARS-CoV-2 Vaccination in Immunocompromised Patients
#COVIDー19
Read the full article #openaccess here:
https://t.co/IGPnUl5sE7
Modeling the Impact of Ensitrelvir on SARS-CoV-2 Dynamics and Its Application for Assessment of Transmission Mitigation of Patients with COVID-19: https://t.co/B89nb03tVD
This study, just published in Infectious Diseases and Therapy, evaluated the value-based price of the RSVpreF vaccine for pregnant people used for prevention of RSV-LRTI among infants in Argentina: https://t.co/65x1znwf2z
Navigating the Current Treatment Landscape of Metallo-β-Lactamase-Producing Gram-Negative Infections: What are the Limitations? https://t.co/4A83kMkE6V
Combination Versus Monotherapy for Carbapenem-Resistant Acinetobacter Species Serious Infections: A Prospective IPTW Adjusted Cohort Study: https://t.co/DusmpxUyFH
Disease Burden Associated with All Infants in Their First RSV Season in the UK: A Static Model of Universal Immunization with Nirsevimab Against RSV-Related Outcomes
https://t.co/78gIPhPL9l
Efficacy and Safety of Low-Dose, Rapidly Infused Bamlanivimab and Etesevimab: Phase 3 BLAZE-1 Trial for Mild-to-Moderate COVID-19: https://t.co/78gIPhPL9l
Mycoplasma hominis as Cause of Extragenital Infection in Patients with Hypogammaglobulinemia: Report of 2 Cases and Literature Review: https://t.co/q6auO3mb0F
The latest piece of research published in Infectious Diseases and Therapy looked at the extracorporeal removal of cytokines from the bloodstream, and the potential of this therapy to help in treating septic shock. More here: https://t.co/YDOQB9TpGt
New research just published in Infectious Diseases and Therapy describes a model which estimated the cost benefits of using the antiviral drug baloxavir, compared to oseltamivir or no treatment for #influenza patients.
https://t.co/gXwY5p1hdu
How do we define long-COVID for better research, diagnostics and treatment? In this commentary, just published in Infectious Diseases & Therapy, the authors propose refinement into three sub-groups - read more here:
https://t.co/foPgtazAf0
"Proportion of Patients in the United States Who Fill Their Nirmatrelvir/Ritonavir Prescriptions"
Available #openaccess here: https://t.co/UXqA8BihDO
#covid19#infectiousdiseases